Health care stocks declined Friday afternoon with the NYSE Health Care Index down 0.6% and the Health Care Select Sector SPDR Fund (XLV) easing 0.1%.
The iShares Biotechnology ETF (IBB) rose 0.3%.
In corporate news, Novo Nordisk (NVO) shares fell 5.6% after the Department of Health and Human Services said the company's Ozempic, Wegovy and Rybelsus are among the 15 additional drugs selected for US Medicare price negotiations.
Zentek (ZTEK) shares jumped 18% as the company expects to begin sales of its ZenGUARD enhanced air filters in Canada by the end of March.
Zai Lab (ZLAB) said its new drug application for KarXT to treat adult patients with schizophrenia was accepted by China's National Medical Products Administration. Its shares rose 2%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。